Torun Litzén
Director of Corporate Communication
+46 70 762 00 50
Switchboard: +46 8 562 000 00
Newsroom
Latest press releases
Kinnevik leads USD 150 million private placement in Recursion with USD 75 million investment
Kinnevik AB (publ) ("Kinnevik”) today announced that it has invested USD 75m in Recursion, a US-based clinical-stage biotechnology company industrializing drug discovery by decoding biology. Recursion is listed on NASDAQ under the ticker RXRX.
Read full press releaseKinnevik’s Interim Report 1 January – 30 September 2022
”Geopolitical and macroeconomic unrest continues to provide a challenging market backdrop for investors. For Kinnevik, the pressure on market multiples has had a negative impact on valuations and the fundraising environment is clearly more demanding than last year. However, our pipeline remains strong, albeit with deal flow coming at a slower pace. In this environment, our strong financial position and the strides we have taken in building out a broad, significant and balanced growth portfolio allow us not only to double down in the existing portfolio, but also to explore new and adjacent themes and sectors. In addition, we are looking for opportunities for consolidation, such as the proposed combination of Budbee and Instabox.”
Read full press release
Subscribe to news from Kinnevik
Kinnevik on Instagram
Media contact
